# Claritin Reditabs

NDC: 11523-7202
Generic name: Loratadine
Labeler / Manufacturer: Bayer HealthCare LLC
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20061212

FDA application: NDA021993

## Active ingredients

- LORATADINE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11523-7202"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11523-7202
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7dc04b48-f053-4e4b-a493-9e8286d2a791